Ancient herbal mix tested for stubborn eczema in small trial
NCT ID NCT04686955
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 3 trial tested a Chinese herbal formula called Xiao-Xian-Gui-Fu-Tang in 19 people aged 6 to 30 with moderate to severe atopic dermatitis (eczema). Participants took the herbal blend or a placebo for several weeks. Researchers measured changes in eczema severity and quality of life. The study aims to see if adding traditional Chinese medicine can help control this chronic skin condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Xiao-Xian-Gui-Fu-Tang (a blend of Chinese herbs including Xiao-Feng-San, Dang-Gui-Yin-Zi, Bai-Xian-Pi, and Di-Fu-Zi)
- What this could lead to
- If effective, this herbal formula could offer an additional treatment option for people with moderate to severe atopic dermatitis, potentially reducing symptoms and improving quality of life.
- What could go wrong
- This is a very small Phase 3 trial with only 19 participants, so results may not apply to a broader population. The study is completed but no results are posted yet, and the herbal mixture may cause side effects or interact with other medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
19 people
The number who actually took part.
- Started
-
Jan 2021
- Finished
-
Dec 2022
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 30 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 6 years old to 30 years old. * Diagnosis as an atopic dermatitis patient. * The score of the SCORAD is over 25. (moderate to severe atopic dermatitis) Exclusion Criteria: * Secondary bacterial infections * Received oral or intravenous steroid treatment, anti-biotics, phototherapy, or other immunosuppressive therapies in the previous 2 months. * Received Chinese herbal medicine treatment or acupuncture. * Pregnant woman or current breastfeeding. * Who had catastrophes illness now or in the past must be avoided. * Can not sign informed consent or can not communicate with the researcher. * Abnormal liver enzymes. * Abnormal kidney function tests (1.5 times higher than the upper normal limit)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atopic dermatitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Traditional Medicine, Taipei VGH
Taipei, 11217, Taiwan
-
Taipei Veterans General Hospital
Taipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Skin scans may predict who responds to dupilumab for eczema
- Can a daily liquid medicine calm severe eczema in toddlers and preschoolers?
- Scientists probe whether lebrikizumab rewires diseased skin at the molecular level
- Can a Lab-Made antibody calm severe eczema?
- Is your nose fueling infected eczema and scabies sores?
- Can an eczema drug reshape the Skin's microbial community?